• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从组织角度应对医疗相关感染和抗菌药物耐药性:进展与挑战。

Addressing healthcare-associated infections and antimicrobial resistance from an organizational perspective: progress and challenges.

机构信息

Imperial College Centre for Patient Safety and Service Quality, Faculty of Medicine, Imperial College London, 5th floor Medical School Building, St Mary's Campus, Norfolk Place, London W2 1PG, UK.

出版信息

J Antimicrob Chemother. 2012 Jul;67 Suppl 1:i29-36. doi: 10.1093/jac/dks200.

DOI:10.1093/jac/dks200
PMID:22855876
Abstract

This paper explores the progress and challenges associated with the application of organizational factors and approaches to infection prevention and control (IPC) and antibiotic stewardship (AS) in England, many of which have been considered and supported by the Advisory Committee on Antimicrobial Resistance and Healthcare-associated Infections (ARHAI). An organizational perspective is described and the wider macro context and socio-political forces that shape an organizational approach are considered. Factors that drive organizational change in IPC and AS are discussed. The tensions, constraints and dilemmas that can occur are identified and outstanding challenges are debated. Some recommendations for the future direction of IPC and AS organizationally focused strategies and research are proposed.

摘要

本文探讨了在英格兰将组织因素和方法应用于感染预防和控制 (IPC) 和抗生素管理 (AS) 方面的进展和挑战,其中许多因素已经被抗菌素耐药性和医院感染咨询委员会 (ARHAI) 考虑和支持。本文描述了一个组织视角,并考虑了影响组织方法的更广泛的宏观背景和社会政治力量。讨论了推动 IPC 和 AS 组织变革的因素。确定了可能出现的紧张、限制和困境,并就悬而未决的挑战进行了辩论。为今后以组织为重点的 IPC 和 AS 战略和研究提出了一些建议。

相似文献

1
Addressing healthcare-associated infections and antimicrobial resistance from an organizational perspective: progress and challenges.从组织角度应对医疗相关感染和抗菌药物耐药性:进展与挑战。
J Antimicrob Chemother. 2012 Jul;67 Suppl 1:i29-36. doi: 10.1093/jac/dks200.
2
Current challenges in antimicrobial resistance and healthcare-associated infections: role and organization of ARHAI.当前抗菌药物耐药性和与医疗保健相关感染的挑战:ARHAI 的作用和组织。
J Antimicrob Chemother. 2012 Jul;67 Suppl 1:i3-10. doi: 10.1093/jac/dks204.
3
Combating antimicrobial resistance and healthcare-associated infections: the role of the Specialist Advisory Committee on Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI), 2007-2011. Preface.对抗抗菌素耐药性和医疗保健相关感染:抗菌素耐药性和医疗保健相关感染专家咨询委员会(ARHAI)的作用,2007 - 2011年。前言。
J Antimicrob Chemother. 2012 Jul;67 Suppl 1:i1. doi: 10.1093/jac/dks205.
4
Comparison of national strategies to reduce meticillin-resistant Staphylococcus aureus infections in Japan and England.日本和英国降低耐甲氧西林金黄色葡萄球菌感染的国家策略比较。
J Hosp Infect. 2018 Nov;100(3):280-298. doi: 10.1016/j.jhin.2018.06.026. Epub 2018 Jul 7.
5
Effects of Antibiotic Cycling Policy on Incidence of Healthcare-Associated MRSA and Clostridioides difficile Infection in Secondary Healthcare Settings.抗生素轮替政策对二级医疗机构中医疗相关性耐甲氧西林金黄色葡萄球菌和艰难梭菌感染发生率的影响。
Emerg Infect Dis. 2019 Jan;25(1):52-62. doi: 10.3201/eid2501.180111.
6
Recommendations for surveillance priorities for healthcare-associated infections and criteria for their conduct.推荐用于医疗保健相关感染监测重点和开展这些监测的标准。
J Antimicrob Chemother. 2012 Jul;67 Suppl 1:i23-8. doi: 10.1093/jac/dks198.
7
The interface between COVID-19 and bacterial healthcare-associated infections.新冠病毒与细菌所致的医疗保健相关性感染的界面。
Clin Microbiol Infect. 2021 Dec;27(12):1772-1776. doi: 10.1016/j.cmi.2021.06.001. Epub 2021 Jun 7.
8
Education of healthcare professionals and the public.医疗卫生专业人员和公众的教育。
J Antimicrob Chemother. 2012 Jul;67 Suppl 1:i11-8. doi: 10.1093/jac/dks199.
9
Antimicrobial Stewardship and the Infection Control Practitioner: A Natural Alliance.抗菌药物管理与感染控制从业者:天然的联盟。
Infect Dis Clin North Am. 2021 Sep;35(3):771-787. doi: 10.1016/j.idc.2021.04.011.
10
Vital Signs: Estimated Effects of a Coordinated Approach for Action to Reduce Antibiotic-Resistant Infections in Health Care Facilities - United States.生命体征:美国医疗机构中采取协调行动减少抗生素耐药性感染的估计效果
MMWR Morb Mortal Wkly Rep. 2015 Aug 7;64(30):826-31.

引用本文的文献

1
Antibiotic Stewardship in Surgical Departments.外科科室的抗生素管理
Antibiotics (Basel). 2024 Apr 4;13(4):329. doi: 10.3390/antibiotics13040329.
2
Core Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education and Research Consortium.抗真菌药物管理核心推荐:真菌病研究组教育和研究联盟的声明。
J Infect Dis. 2020 Aug 5;222(Suppl 3):S175-S198. doi: 10.1093/infdis/jiaa394.
3
Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approach.未来 30 年的抗菌药物耐药性:人类、细菌和药物——有远见的方法。
Intensive Care Med. 2017 Oct;43(10):1464-1475. doi: 10.1007/s00134-017-4878-x. Epub 2017 Jul 21.
4
Forecasting ESKAPE infections through a time-varying auto-adaptive algorithm using laboratory-based surveillance data.使用基于实验室监测数据的时变自适应算法预测ESKAPE感染。
BMC Infect Dis. 2014 Dec 6;14:634. doi: 10.1186/s12879-014-0634-9.
5
Infection control best practices in clinical research in resource-limited settings.资源有限环境下临床研究中的感染控制最佳实践。
J Acquir Immune Defic Syndr. 2014 Jan 1;65 Suppl 1(0 1):S15-8. doi: 10.1097/QAI.0000000000000034.